Welcome to Coulter Partners Global (English)

19 October 2023

Top hires for VC & PE portfolio companies Q3-2023

Search Highlights

Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.

This quarter’s successful placements include:

Function Focus area Location
CEO Medical equipment France
CEO (US-based) CAR-T therapies UK
Chief Product Officer EHR data platform Spain
Chief Scientific Officer tRNA-based therapeutics US
Chief Financial Officer R&D consulting services US
Group Chief Financial Officer Outpatient services (aesthetic medicine) Switzerland
Chief Business Officer (US-based) AI for drug discovery Central & Eastern Europe
Head of Business Development, North America Contract research organisation Canada
VP Clinical Affairs Analgesic products US
VP Operations Bio-electrical implantable devices UK
VP Global Program Lead (US-based) Multi-modality biotech UK
Country Regional Director Veterinary services Nordics
Chair Protein therapeutics UK
Board Director Oncology drug discovery Germany

Newly opened projects include:

Function Focus area Location
CEO Medical devices Israel
CEO Outpatient services Germany
Country CEO Healthcare services Sweden
Chief Strategy Officer Endoscopic devices Israel
Chief Product Officer Medical information services UK
Chief Medical Officer Small molecules Italy
Head of Drug Metabolism & Pharmacokinetics CNS platform technology UK
Head of TechOps Radiopharmaceuticals China
VP Business Development Transplant technology US
VP Sales Digital pathology solutions France
Managing Director Private equity investor US
Head of Alliance Management Life sciences incubator UK
General Manager Infectious Diseases Biocluster France
Chair Digital therapeutics/ devices US
Board Director Precision contract manufacturing US


A new version of Coulter Partners is available.